Singapore, Dec. 18 -- Germany-based numares Health, the transformative metabolomics company pioneering multidimensional biomarker insights that deliver clinical pathways for optimal patient care, has announced the expansion of its global footprint into the ASEAN region having received regulatory approval in Malaysia and subsequently securing its first contract for the AXINON(R)LDLp Test Systemwith BioD Medica, who specialise in introducing medical devices and healthcare technology into Malaysia and Singapore.

This is the first regulatory approval in the ASEAN region for the AXINON(R) LDLp Test System. Concurrently, numares has secured its first contract with BioD Medica, who specialise in introducing medical devices and healthcare techno...